Oil prices end higher as investors shake off rise in U.S. crude inventories

• Investors call for shake-up of Europe’s ‘failed’ securitisation market

  Fund managers and insurers say long-overdue reforms could unlock hundreds of billions of euros in financing
  
  Financial Times - 14h

• Moscow loathed the U.S. for years as its economy paid a high price for war — now, it’s doing a U-turn

  Moscow has denigrated the United States' leadership, economy and culture — but now things are changing amid a "revival" of Russia-U.S. relations.
  
  CNBC - 1d
• 

  After 18 Years, Apple Just Killed Off 1 of Its Most Iconic iPhone Features. It’s the End of an Era

  The all-new iPhone 16e ditches the Home Button for good.
  
  Inc. - 2d

• Canada defeats U.S. 3-2 to win 4 Nations Face-Off Championship

  The North American rivals turned what had been a tune-up for the 2026 Olympics into an geopolitical brawl over anthems and annexation as much as international hockey supremacy.
  
  CBS News - 14h
• 

  The 3 Best Essential Oil Diffusers (and One to Avoid)

  Keep things smelling fresh with these handy home gadgets.
  
  Wired - 1d

• Oil heads for weekly gains on supply worries, but remains stuck in range

  “A number of decisions are pending … could drive the oil price in one direction or the other,” one analyst notes.
  
  MarketWatch - 6h
• 

  Fed Flags Rising Inflation Risks and Rising Uncertainty About Trump’s Policies

  Rates cuts are still on the menu, but like many businesses, Fed officials are having a tough time judging the impact of Trump’s tariff and immigration plans.
  
  Inc. - 20h
• 

  What does DOGE's IRS shake-up mean for tax season?

  DOGE wants access to filers’ data, and the commerce secretary says Trump wants to scrap the IRS. But filing a return remains mandatory — the earlier the better, tax advisers say.
  
  NBC News - 21h

• What might an optimistic investor buy in the UK?

  The outlook is far from rosy, but what if we’re overdoing the doom and gloom?
  
  Financial Times - 7h

• The Price You Pay: Egg prices’ impact on bakeries

  One of the downstream impacts of bird flu and the soaring egg prices: its impact on bakeries. We visit one Pittsburgh bakery struggling that’s seen egg prices soar in the last two years, and the ...
  
  NBC News - 19h

More from MarketWatch

• What are Trump’s USPS plans? His past postal-service comments offer clues.

  President Donald Trump could be working on an overhaul for the U.S. Postal Service, though the White House is pushing back on the growing expectations on that front.
  
  MarketWatch - 17m

• FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.

  “We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.
  
  MarketWatch - 32m

• Can you trust Elon Musk and his ‘DOGE’ claims about government fraud?

  American people deserve answers about what these Washington outsiders-turned-insiders are up to
  
  MarketWatch - 38m

• Gold may soar past $3,000 — but at these prices you’re overpaying

  Why you can expect below-average returns from gold in coming years.
  
  MarketWatch - 47m

• Nvidia options traders are vastly overestimating how earnings will move the stock. Just look at these charts.

  Nvidia options aren’t a good trade, this expert says. Here’s what he likes.
  
  MarketWatch - 51m

More in Business

• Elon Musk has a problem with X's Community Notes when he disapproves of the results

  Elon Musk on Thursday claimed that X's Community Notes needs a "fix" because the service can allegedly be "gamed."
  
  CNBC - 9m

• Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

  Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage
  
  CNBC - 10m

• What are Trump’s USPS plans? His past postal-service comments offer clues.

  President Donald Trump could be working on an overhaul for the U.S. Postal Service, though the White House is pushing back on the growing expectations on that front.
  
  MarketWatch - 17m

• Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker

  Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
  
  CNBC - 20m

• With tariffs ramping up, this investment option can provide protection against inflation

  The threat of tariffs on imports is causing some investors to consider increasing their exposure to TIPS to help buffer their portfolios against inflation.
  
  CNBC - 20m